{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T12:58:54Z","timestamp":1781787534232,"version":"3.54.5"},"reference-count":212,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100032209","name":"Saudi National Institute of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100032209","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["PRI01-2401-QU008-46530391"],"award-info":[{"award-number":["PRI01-2401-QU008-46530391"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virus Research"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.virusres.2026.199720","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T16:07:47Z","timestamp":1775059667000},"page":"199720","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["A systematic review on vaccine developmental approaches: Evaluating efficacy, and addressing challenges of infectious diseases in the post-COVID-19 era"],"prefix":"10.1016","volume":"367","author":[{"given":"Mduduzi N.","family":"Sithole","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohaimin R.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamdoon A.","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riaz A.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kruti","family":"Naik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3889-1529","authenticated-orcid":false,"given":"Yahya E.","family":"Choonara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virusres.2026.199720_bib0001","series-title":"Cellular and Molecular Immunology, 10e, South Asia Edition - E-Book","author":"Abbas","year":"2021"},{"key":"10.1016\/j.virusres.2026.199720_bib0002","article-title":"While studies on COVID-19 vaccine is ongoing, the public\u2019s thoughts and attitudes to the future COVID-19 vaccine","volume":"75","author":"Akarsu","year":"2021","journal-title":"Int. J. Clin. Pr."},{"key":"10.1016\/j.virusres.2026.199720_bib0007","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.2147\/JMDH.S276771","article-title":"Determinants of COVID-19 vaccine acceptance in Saudi Arabia: a web-based national survey","volume":"13","author":"Al-Mohaithef","year":"2020","journal-title":"JMDH"},{"key":"10.1016\/j.virusres.2026.199720_bib0008","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2021.632914","article-title":"COVID-19 vaccination acceptance and its associated factors among a Middle Eastern population","volume":"9","author":"Al-Qerem","year":"2021","journal-title":"Front. Public Health"},{"key":"10.1016\/j.virusres.2026.199720_bib0003","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1080\/21645515.2015.1102804","article-title":"Peptide\/protein vaccine delivery system based on PLGA particles","volume":"12","author":"Allahyari","year":"2015","journal-title":"Hum. Vaccin. ImmunOther."},{"key":"10.1016\/j.virusres.2026.199720_bib0004","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.addr.2012.09.037","article-title":"Liposomal drug delivery systems: from concept to clinical applications","volume":"65","author":"Allen","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.virusres.2026.199720_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/cddiscovery.2016.48","article-title":"Bat\u2013man disease transmission: zoonotic pathogens from wildlife reservoirs to human populations","volume":"2","author":"Allocati","year":"2016","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.virusres.2026.199720_bib0006","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jsps.2021.01.001","article-title":"The influence of demographics on influenza vaccine awareness and hesitancy among adults visiting educational hospital in Saudi Arabia","volume":"29","author":"Alzeer","year":"2021","journal-title":"Saudi Pharm. J."},{"key":"10.1016\/j.virusres.2026.199720_bib0009","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1600-065X.2010.00912.x","article-title":"Mechanisms that determine plasma cell lifespan and the duration of humoral immunity","volume":"236","author":"Amanna","year":"2010","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.virusres.2026.199720_bib0010","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41524-017-0050-y","article-title":"Theory, simulations and the design of functionalized nanoparticles for biomedical applications: a soft matter perspective","volume":"3","author":"Angioletti-Uberti","year":"2017","journal-title":"npj Comput. Mater."},{"key":"10.1016\/j.virusres.2026.199720_bib0011","year":"2021"},{"key":"10.1016\/j.virusres.2026.199720_bib0012","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nri2868","article-title":"Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns","volume":"10","author":"Bachmann","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.virusres.2026.199720_bib0013","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1080\/14760584.2025.2508517","article-title":"Virus-like particles: a versatile and effective vaccine platform","volume":"24","author":"Bachmann","year":"2025","journal-title":"Expert. Rev. Vaccines"},{"key":"10.1016\/j.virusres.2026.199720_bib0014","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.virusres.2026.199720_bib0015","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1126\/science.abc2535","article-title":"Susceptible supply limits the role of climate in the early SARS-CoV-2 pandemic","volume":"369","author":"Baker","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.virusres.2026.199720_bib0016","doi-asserted-by":"crossref","first-page":"636","DOI":"10.3390\/vaccines12060636","article-title":"Precision in action: the role of clustered regularly interspaced short palindromic repeats\/cas in gene therapies","volume":"12","author":"Banda","year":"2024","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.virusres.2026.199720_bib0017","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4049\/jimmunol.171.1.27","article-title":"Cutting edge: rapid In vivo killing by memory CD8 T cells","volume":"171","author":"Barber","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.virusres.2026.199720_bib0018","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003354","article-title":"Risk of disease and willingness to vaccinate in the United States: a population-based survey","volume":"17","author":"Baumgaertner","year":"2020","journal-title":"PLoS Med."},{"key":"10.1016\/j.virusres.2026.199720_bib0019","doi-asserted-by":"crossref","first-page":"7789","DOI":"10.1016\/j.vaccine.2020.10.027","article-title":"Parents\u2019 and guardians\u2019 views on the acceptability of a future COVID-19 vaccine: a multi-methods study in England","volume":"38","author":"Bell","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2026.199720_bib0020","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S1473-3099(16)00129-8","article-title":"Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies","volume":"16","author":"Belongia","year":"2016","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.virusres.2026.199720_bib0021","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.3390\/vaccines10111946","article-title":"Nanoparticle-based delivery systems for vaccines","volume":"10","author":"Bezbaruah","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.virusres.2026.199720_bib0022","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1743-8977-7-3","article-title":"Multifunctional nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging","volume":"7","author":"Bhaskar","year":"2010","journal-title":"Part Fibre Toxicol."},{"key":"10.1016\/j.virusres.2026.199720_bib0023","series-title":"Covid-19 Risks and Response in South Asia","author":"Bhutta","year":"2020"},{"key":"10.1016\/j.virusres.2026.199720_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2020.101051","article-title":"Potential immuno-nanomedicine strategies to fight COVID-19 like pulmonary infections","volume":"36","author":"Bonam","year":"2021","journal-title":"Nano Today"},{"key":"10.1016\/j.virusres.2026.199720_bib0025","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1007\/s13346-024-01635-5","article-title":"Nanoemulsions and nanocapsules as carriers for the development of intranasal mRNA vaccines","volume":"14","author":"Borrajo","year":"2024","journal-title":"Drug Deliv. Transl. Res"},{"key":"10.1016\/j.virusres.2026.199720_bib0026","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.vaccine.2020.12.032","article-title":"Preferences for a COVID-19 vaccine in Australia","volume":"39","author":"Borriello","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2026.199720_bib0027","doi-asserted-by":"crossref","DOI":"10.3389\/frans.2024.1358893","article-title":"Reliable particle sizing in vaccine formulations using advanced dynamic light scattering","volume":"4","author":"Bretz","year":"2024","journal-title":"Front. Anal. Sci."},{"key":"10.1016\/j.virusres.2026.199720_bib0028","first-page":"E455","article-title":"Trends in influenza vaccine coverage and vaccine hesitancy in Canada, 2006\/07 to 2013\/14: results from cross-sectional survey data","volume":"4","author":"Buchan","year":"2016","journal-title":"Can. Med. Assoc. Open Access J."},{"key":"10.1016\/j.virusres.2026.199720_bib0029","series-title":"Immune Therapy for Infectious Diseases at the Dawn of the 21st Century: the Past, Present and Future Role of Antibody Therapy","author":"Buchwald","year":"2003"},{"key":"10.1016\/j.virusres.2026.199720_bib0030","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.3390\/vaccines12101087","article-title":"Formulation attributes impact immune profile of an oral and thermostable COVID-19 subunit vaccine","volume":"12","author":"Burlet","year":"2024","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.virusres.2026.199720_bib0031","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.00503-23","article-title":"Exosome-based multivalent vaccine: achieving potent immunization, broadened reactivity, and strong T-cell responses with nanograms of proteins","volume":"11","author":"Cacciottolo","year":"2023","journal-title":"Microbiol. Spectr."},{"issue":"1982","key":"10.1016\/j.virusres.2026.199720_bib0032","article-title":"Correlates and disparities of intention to vaccinate against COVID-19","volume":"272","author":"Callaghan","year":"2021","journal-title":"Soc. Sci. Med."},{"key":"10.1016\/j.virusres.2026.199720_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2021.198454","article-title":"The COVID-19 vaccine development: a pandemic paradigm","volume":"301","author":"Carneiro","year":"2021","journal-title":"Virus. Res."},{"key":"10.1016\/j.virusres.2026.199720_bib0034","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2174\/1566524054022567","article-title":"Insights into mechanisms of antibody-mediated immunity from studies with cryptococcus neoformans","volume":"5","author":"Casadevall","year":"2005","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.virusres.2026.199720_bib0035","doi-asserted-by":"crossref","first-page":"244","DOI":"10.7150\/ntno.19796","article-title":"Nanoparticle vaccines adopting virus-like features for enhanced immune potentiation","volume":"1","author":"Chattopadhyay","year":"2017","journal-title":"Nanotheranostics"},{"key":"10.1016\/j.virusres.2026.199720_bib0036","doi-asserted-by":"crossref","DOI":"10.1038\/srep36921","article-title":"Inhibition of JCPyV infection mediated by targeted viral genome editing using CRISPR\/Cas9","volume":"6","author":"Chou","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.virusres.2026.199720_bib0037","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.humimm.2021.05.001","article-title":"Chemotherapy vs. Immunotherapy in combating nCOVID19: an update","volume":"82","author":"Choudhury","year":"2021","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.virusres.2026.199720_bib0038","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3390\/genes9030144","article-title":"Cell-free approaches in synthetic biology utilizing microfluidics","volume":"9","author":"Damiati","year":"2018","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.virusres.2026.199720_bib0039","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jconrel.2012.01.043","article-title":"PLGA-based nanoparticles: an overview of biomedical applications","volume":"161","author":"Danhier","year":"2012","journal-title":"J. Control Release"},{"key":"10.1016\/j.virusres.2026.199720_bib0040","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/jcp.24791","article-title":"Gene therapies for cancer: strategies, challenges and successes","volume":"230","author":"Das","year":"2015","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.virusres.2026.199720_bib0041","doi-asserted-by":"crossref","first-page":"26984","DOI":"10.1021\/acsami.4c00208","article-title":"Electrophoretic microfluidic characterization of mRNA- and pDNA-loaded lipid nanoparticles","volume":"16","author":"De Pe\u00f1a","year":"2024","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.virusres.2026.199720_bib0042","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1093\/infdis\/jis923","article-title":"Largest measles epidemic in North America in a decade\u2014Quebec, Canada, 2011: contribution of susceptibility, serendipity, and superspreading events","volume":"207","author":"De Serres","year":"2013","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virusres.2026.199720_bib0043","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3390\/vaccines13010025","article-title":"Development of a cationic polymeric micellar structure with endosomal escape capability enables enhanced intramuscular transfection of mRNA-LNPs","volume":"13","author":"Deng","year":"2024","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.virusres.2026.199720_bib0044","doi-asserted-by":"crossref","first-page":"7002","DOI":"10.1016\/j.vaccine.2020.09.041","article-title":"Intention to participate in a COVID-19 vaccine clinical trial and to get vaccinated against COVID-19 in France during the pandemic","volume":"38","author":"Detoc","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2026.199720_bib0045","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/d41586-021-02483-w","article-title":"The tangled history of mRNA vaccines","volume":"597","author":"Dolgin","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.virusres.2026.199720_bib0046","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1111\/hex.13140","article-title":"Public preference for COVID-19 vaccines in China: a discrete choice experiment","volume":"23","author":"Dong","year":"2020","journal-title":"Health Expect"},{"key":"10.1016\/j.virusres.2026.199720_bib0047","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1208\/s12249-018-1254-2","article-title":"Stability of vaccines","volume":"20","author":"Dumpa","year":"2019","journal-title":"AAPS. PharmSciTech."},{"key":"10.1016\/j.virusres.2026.199720_bib0048","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009453","article-title":"A human coronavirus evolves antigenically to escape antibody immunity","volume":"17","author":"Eguia","year":"2021","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virusres.2026.199720_bib0049","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.2147\/IJGM.S310497","article-title":"Minor to moderate side effects of Pfizer-BioNTech COVID-19 vaccine among Saudi residents: a retrospective cross-sectional study","volume":"14","author":"El-Shitany","year":"2021","journal-title":"IJGM"},{"key":"10.1016\/j.virusres.2026.199720_bib0050","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2023-011879","article-title":"Factors, enablers and challenges for COVID-19 vaccine development","volume":"8","author":"Excler","year":"2023","journal-title":"BMJ Glob. Health"},{"key":"10.1016\/j.virusres.2026.199720_bib0051","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2020.551004","article-title":"Public perceptions of COVID-19 in Australia: perceived risk, knowledge, health-protective behaviors, and vaccine intentions","volume":"11","author":"Faasse","year":"2020","journal-title":"Front. Psychol."},{"key":"10.1016\/j.virusres.2026.199720_bib0052","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.3390\/vaccines11071172","article-title":"Nanoparticle-based adjuvants and delivery systems for modern vaccines","volume":"11","author":"Filipi\u0107","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.virusres.2026.199720_bib0053","doi-asserted-by":"crossref","first-page":"964","DOI":"10.7326\/M20-3569","article-title":"Attitudes toward a potential SARS-CoV-2 vaccine: a survey of U.S. Adults","volume":"173","author":"Fisher","year":"2020","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.virusres.2026.199720_bib0054","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1017\/S0033291720005188","article-title":"COVID-19 vaccine hesitancy in the UK: the Oxford coronavirus explanations, attitudes, and narratives survey (Oceans) II","volume":"52","author":"Freeman","year":"2022","journal-title":"Psychol. Med."},{"key":"10.1016\/j.virusres.2026.199720_bib0055","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jhin.2020.11.020","article-title":"Intention to get vaccinations against COVID-19 in French healthcare workers during the first pandemic wave: a cross-sectional survey","volume":"108","author":"Gagneux-Brunon","year":"2021","journal-title":"J. Hosp. Infect."},{"key":"10.1016\/j.virusres.2026.199720_bib0056","doi-asserted-by":"crossref","unstructured":"Grech, V., Gauci, C., 2020. WITHDRAWN: vaccine hesitancy in the University of Malta Faculties of Health Sciences, Dentistry and Medicine vis-\u00e0-vis influenza and novel COVID-19 vaccination.","DOI":"10.1016\/j.earlhumdev.2020.105258"},{"key":"10.1016\/j.virusres.2026.199720_bib0057","doi-asserted-by":"crossref","unstructured":"Grech, V., Gauci, C., Agius, S., 2020. Withdrawn: vaccine hesitancy among Maltese healthcare workers toward influenza and novel COVID-19 vaccination.","DOI":"10.1016\/j.earlhumdev.2020.105213"},{"key":"10.1016\/j.virusres.2026.199720_bib0058","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3389\/fcimb.2013.00013","article-title":"Vaccine delivery using nanoparticles","volume":"3","author":"Gregory","year":"2013","journal-title":"Front. Cell Infect. Microbiol."},{"key":"10.1016\/j.virusres.2026.199720_bib0059","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ajic.2020.11.018","article-title":"Willingness to get the COVID-19 vaccine with and without emergency use authorization","volume":"49","author":"Guidry","year":"2021","journal-title":"Am. J. Infect. Control"},{"key":"10.1016\/j.virusres.2026.199720_bib0060","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1515\/ntrev-2019-0014","article-title":"Applications of polymer-based nanoparticles in vaccine field","volume":"8","author":"Guo","year":"2019","journal-title":"Nanotechnol. Rev."},{"key":"10.1016\/j.virusres.2026.199720_bib0062","series-title":"Novel Strategies in the Design and Production of Vaccines","first-page":"105","article-title":"The role of adjuvants and delivery systems in modulation of immune response to vaccines","author":"Gupta","year":"1996"},{"key":"10.1016\/j.virusres.2026.199720_bib0061","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1123805","article-title":"Platforms, advances, and technical challenges in virus-like particles-based vaccines","volume":"14","author":"Gupta","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.virusres.2026.199720_bib0063","unstructured":"Hammond, J., 2020. Vaccine confidence, coverage, and hesitancy worldwide: a literature analysis of vaccine hesitancy and potential causes worldwide."},{"key":"10.1016\/j.virusres.2026.199720_bib0064","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ygyno.2017.04.004","article-title":"HPV vaccines\u2013a review of the first decade","volume":"146","author":"Harper","year":"2017","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.virusres.2026.199720_bib0065","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ijid.2020.06.075","article-title":"Comparing COVID-19 and the 1918\u201319 influenza pandemics in the United Kingdom","volume":"98","author":"He","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.virusres.2026.199720_bib0066","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1177\/1075547020960463","article-title":"A national survey assessing SARS-CoV-2 vaccination intentions: implications for future public health communication efforts","volume":"42","author":"Head","year":"2020","journal-title":"Sci. Commun."},{"key":"10.1016\/j.virusres.2026.199720_bib0067","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(16)32621-6","article-title":"Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola \u00c7a Suffit!)","volume":"389","author":"Henao-Restrepo","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.virusres.2026.199720_bib0068","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1098\/rstb.2011.0091","article-title":"Vaccines against malaria","volume":"366","author":"Hill","year":"2011","journal-title":"Philos. Trans. R. Soc. B: Biol. Sci."},{"key":"10.1016\/j.virusres.2026.199720_bib0069","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","article-title":"Lipid nanoparticles for mRNA delivery","volume":"6","author":"Hou","year":"2021","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.virusres.2026.199720_bib0070","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.virusres.2026.199720_bib0071","series-title":"International Coalition of Medicines Regulatory Authorities (ICMRA)","author":"ICMRA","year":"2018"},{"key":"10.1016\/j.virusres.2026.199720_bib0072","doi-asserted-by":"crossref","first-page":"11109","DOI":"10.1021\/acs.chemrev.5b00109","article-title":"Synthetic nanoparticles for vaccines and immunotherapy","volume":"115","author":"Irvine","year":"2015","journal-title":"Chem. Rev."},{"key":"10.1016\/j.virusres.2026.199720_bib0073","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1056\/NEJMra1706169","article-title":"Chimeric antigen receptor therapy","volume":"379","author":"June","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.virusres.2026.199720_bib0074","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2007538118","article-title":"Concerns for others increase the likelihood of vaccination against influenza and COVID-19 more in sparsely rather than densely populated areas","volume":"118","author":"Jung","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"issue":"5517","key":"10.1016\/j.virusres.2026.199720_bib0083","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/256495a0","article-title":"Continuous cultures of fused cells secreting antibody of predefined specificity","volume":"256","author":"K\u00f6hler","year":"1975","journal-title":"Nature"},{"key":"10.1016\/j.virusres.2026.199720_bib0075","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2147\/POR.S271096","article-title":"Acceptability of vaccination against COVID-19 among healthcare workers in the Democratic Republic of the Congo","volume":"11","author":"Kabamba Nzaji","year":"2020","journal-title":"POR Vol."},{"key":"10.1016\/j.virusres.2026.199720_bib0076","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/nri3307","article-title":"Transcriptional control of effector and memory CD8+ T cell differentiation","volume":"12","author":"Kaech","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.virusres.2026.199720_bib0077","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.molimm.2018.11.015","article-title":"A role for Th1-like Th17 cells in the pathogenesis of inflammatory and autoimmune disorders","volume":"105","author":"Kamali","year":"2019","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.virusres.2026.199720_bib0078","article-title":"Genomic characterization of a novel SARS-CoV-2","volume":"19","author":"Khailany","year":"2020","journal-title":"Gene Rep."},{"key":"10.1016\/j.virusres.2026.199720_bib0080","doi-asserted-by":"crossref","first-page":"603","DOI":"10.4269\/ajtmh.20-0654","article-title":"Threat of COVID-19 vaccine hesitancy in Pakistan: the need for measures to neutralize misleading narratives","volume":"103","author":"Khan","year":"2020","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.virusres.2026.199720_bib0079","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1039\/D2NA00795A","article-title":"Lipid-based colloidal nanoparticles for applications in targeted vaccine delivery","volume":"5","author":"Khan","year":"2023","journal-title":"Nanoscale Adv."},{"key":"10.1016\/j.virusres.2026.199720_bib0081","doi-asserted-by":"crossref","DOI":"10.1002\/biot.201800376","article-title":"Emerging technologies for low-cost, rapid vaccine manufacture","volume":"14","author":"Kis","year":"2019","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.virusres.2026.199720_bib0082","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1126\/science.abb5793","article-title":"Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period","volume":"368","author":"Kissler","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.virusres.2026.199720_bib0084","first-page":"383","article-title":"Emergency use authorization of covid vaccines \u2014 Safety and efficacy follow-up considerations","author":"Krause","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.virusres.2026.199720_bib0085","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.25594","article-title":"Factors associated with US adults\u2019 likelihood of accepting COVID-19 vaccination","volume":"3","author":"Kreps","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.virusres.2026.199720_bib0086","doi-asserted-by":"crossref","DOI":"10.1115\/1.4053273","article-title":"Smart vaccine manufacturing using novel biotechnology platforms: a study during COVID-19","volume":"22","author":"Kumar","year":"2022","journal-title":"J. Comput. Inf. Sci. Eng."},{"key":"10.1016\/j.virusres.2026.199720_bib0087","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijnurstu.2020.103854","article-title":"Influenza vaccine uptake, COVID-19 vaccination intention and vaccine hesitancy among nurses: a survey","volume":"114","author":"Kwok","year":"2021","journal-title":"Int. J. Nurs. Stud."},{"key":"10.1016\/j.virusres.2026.199720_bib0088","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41591-020-1124-9","article-title":"A global survey of potential acceptance of a COVID-19 vaccine","volume":"27","author":"Lazarus","year":"2021","journal-title":"Nat. Med"},{"key":"10.1016\/j.virusres.2026.199720_bib0089","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.vaccine.2020.12.009","article-title":"Individual preferences for COVID-19 vaccination in China","volume":"39","author":"Leng","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2026.199720_bib0090","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.3390\/vaccines12121379","article-title":"Evaluation of the efficacy of the vaccine production process in removing residual host cell DNA from the Vero cell rabies vaccine","volume":"12","author":"Li","year":"2024","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.virusres.2026.199720_bib0091","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008961","article-title":"Understanding COVID-19 vaccine demand and hesitancy: a nationwide online survey in China","volume":"14","author":"Lin","year":"2020","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.virusres.2026.199720_bib0092","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3390\/jfb16050185","article-title":"Nano\/micro-enabled modification and innovation of conventional adjuvants for next-generation vaccines","volume":"16","author":"Liu","year":"2025","journal-title":"J. Funct. Biomater."},{"key":"10.1016\/j.virusres.2026.199720_bib0093","article-title":"The next-generation DNA vaccine platforms and delivery systems: advances, challenges and prospects","volume":"15","author":"Lu","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.virusres.2026.199720_bib0102","doi-asserted-by":"crossref","DOI":"10.1016\/j.nwnano.2024.100058","article-title":"Nanotechnology platforms for antigen and immunostimulant delivery in vaccine formulations","volume":"8","author":"M\u00e1rquez","year":"2024","journal-title":"Nano Trends"},{"key":"10.1016\/j.virusres.2026.199720_bib0094","doi-asserted-by":"crossref","first-page":"4161","DOI":"10.1016\/j.vaccine.2015.04.036","article-title":"Vaccine hesitancy: definition, scope and determinants","volume":"33","author":"MacDonald","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2026.199720_bib0095","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.addr.2021.01.002","article-title":"Nanocarrier vaccines for SARS-CoV-2","volume":"171","author":"Machhi","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.virusres.2026.199720_bib0096","doi-asserted-by":"crossref","unstructured":"Mahase, E., 2021. Covid-19: WHO says rollout of AstraZeneca vaccine should continue, as Europe divides over safety.","DOI":"10.1136\/bmj.n728"},{"key":"10.1016\/j.virusres.2026.199720_bib0097","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.3390\/polym3031377","article-title":"Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier","volume":"3","author":"Makadia","year":"2011","journal-title":"Polym. (Basel)"},{"key":"10.1016\/j.virusres.2026.199720_bib0098","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2020.100495","article-title":"Determinants of COVID-19 vaccine acceptance in the US","volume":"26","author":"Malik","year":"2020","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.virusres.2026.199720_bib0099","doi-asserted-by":"crossref","first-page":"6077","DOI":"10.1073\/pnas.86.16.6077","article-title":"Cationic liposome-mediated RNA transfection","volume":"86","author":"Malone","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1016\/j.virusres.2026.199720_bib0100","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/14760584.2019.1552141","article-title":"Vaccination of healthcare workers: is mandatory vaccination needed?","volume":"18","author":"Maltezou","year":"2019","journal-title":"Expert. Rev. Vaccines"},{"key":"10.1016\/j.virusres.2026.199720_bib0101","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1002\/eji.200737984","article-title":"Nanoparticles target distinct dendritic cell populations according to their size","volume":"38","author":"Manolova","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.virusres.2026.199720_bib0103","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/s41562-021-01122-8","article-title":"A global database of COVID-19 vaccinations","volume":"5","author":"Mathieu","year":"2021","journal-title":"Nat. Hum. Behav."},{"key":"10.1016\/j.virusres.2026.199720_bib0104","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.ajic.2015.06.031","article-title":"Social and political determinants of vaccine hesitancy: lessons learned from the H1N1 pandemic of 2009\u20132010","volume":"43","author":"Mesch","year":"2015","journal-title":"Am. J. Infect. Control"},{"key":"10.1016\/j.virusres.2026.199720_bib0105","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.virol.2015.03.032","article-title":"Live attenuated vaccines: historical successes and current challenges","volume":"479","author":"Minor","year":"2015","journal-title":"Virology"},{"key":"10.1016\/j.virusres.2026.199720_bib0106","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s10735-020-09915-3","article-title":"COVID-19 and multiorgan failure: a narrative review on potential mechanisms","volume":"51","author":"Mokhtari","year":"2020","journal-title":"J. Mol. Hist."},{"key":"10.1016\/j.virusres.2026.199720_bib0107","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1073\/pnas.1112648109","article-title":"Enhancing humoral responses to a malaria antigen with nanoparticle vaccines that expand Tfh cells and promote germinal center induction","volume":"109","author":"Moon","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.virusres.2026.199720_bib0108","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1016\/S0140-6736(17)31463-0","article-title":"Measles","volume":"390","author":"Moss","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.virusres.2026.199720_bib0109","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1093\/aje\/kwq320","article-title":"From emergence to eradication: the epidemiology of poliomyelitis deconstructed","volume":"172","author":"Nathanson","year":"2010","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.virusres.2026.199720_bib0110","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s12889-021-10169-1","article-title":"Harmonization of medical products regulation: a key factor for improving regulatory capacity in the East African Community","volume":"21","author":"Ndomondo-Sigonda","year":"2021","journal-title":"BMC. Public Health"},{"key":"10.1016\/j.virusres.2026.199720_bib0111","doi-asserted-by":"crossref","first-page":"380","DOI":"10.3390\/biologics3040021","article-title":"Advances in Escherichia coli-based therapeutic protein expression: mammalian conversion, continuous manufacturing, and cell-free production","volume":"3","author":"Niazi","year":"2023","journal-title":"Biologics."},{"key":"10.1016\/j.virusres.2026.199720_bib0112","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12951-021-00806-7","article-title":"Virus-like particles: preparation, immunogenicity and their roles as nanovaccines and drug nanocarriers","volume":"19","author":"Nooraei","year":"2021","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.virusres.2026.199720_bib0113","doi-asserted-by":"crossref","first-page":"B14","DOI":"10.1016\/j.vaccine.2015.01.088","article-title":"New generation adjuvants\u2013from empiricism to rational design","volume":"33","author":"O\u2019Hagan","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2026.199720_bib0114","article-title":"The state of the antivaccine movement in the United States: a focused examination of nonmedical exemptions in states and counties","volume":"15","author":"Olive","year":"2018","journal-title":"PLoS Med."},{"key":"10.1016\/j.virusres.2026.199720_bib0115","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s10654-020-00675-8","article-title":"Mistrust in biomedical research and vaccine hesitancy: the forefront challenge in the battle against COVID-19 in Italy","volume":"35","author":"Palamenghi","year":"2020","journal-title":"Eur. J. Epidemiol."},{"key":"10.1016\/j.virusres.2026.199720_bib0116","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1080\/21691401.2023.2247036","article-title":"Liposomes for drug delivery: review of vesicular composition, factors affecting drug release and drug loading in liposomes","volume":"51","author":"Pande","year":"2023","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"10.1016\/j.virusres.2026.199720_bib0117","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0169-409X(02)00228-4","article-title":"Biodegradable nanoparticles for drug and gene delivery to cells and tissue","volume":"55","author":"Panyam","year":"2003","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.virusres.2026.199720_bib0118","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines\u2014a new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.virusres.2026.199720_bib0119","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.drudis.2020.03.006","article-title":"Epitope-based vaccine design: a comprehensive overview of bioinformatics approaches","volume":"25","author":"Parvizpour","year":"2020","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.virusres.2026.199720_bib0120","series-title":"Fundamental Immunology","author":"Paul","year":"2012"},{"key":"10.1016\/j.virusres.2026.199720_bib0121","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.0818-9641.2004.01272.x","article-title":"Vaccine adjuvants: current state and future trends","volume":"82","author":"Petrovsky","year":"2004","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.virusres.2026.199720_bib0122","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jconrel.2012.12.029","article-title":"Transfection efficiency and transgene expression kinetics of mRNA delivered in naked and nanoparticle format","volume":"166","author":"Phua","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.virusres.2026.199720_bib0126","series-title":"Vaccines","author":"Plotkin","year":"2008"},{"key":"10.1016\/j.virusres.2026.199720_bib0124","doi-asserted-by":"crossref","first-page":"4064","DOI":"10.1016\/j.vaccine.2017.06.003","article-title":"The complexity and cost of vaccine manufacturing\u2013an overview","volume":"35","author":"Plotkin","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2026.199720_bib0123","doi-asserted-by":"crossref","first-page":"12283","DOI":"10.1073\/pnas.1400472111","article-title":"History of vaccination","volume":"111","author":"Plotkin","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.virusres.2026.199720_bib0125","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1016\/j.vaccine.2019.10.046","article-title":"Updates on immunologic correlates of vaccine-induced protection","volume":"38","author":"Plotkin","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2026.199720_bib0127","doi-asserted-by":"crossref","first-page":"582","DOI":"10.3390\/vaccines8040582","article-title":"Influences on attitudes regarding potential COVID-19 vaccination in the United States","volume":"8","author":"Pogue","year":"2020","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.virusres.2026.199720_bib0128","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.virusres.2026.199720_bib0129","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41577-020-00479-7","article-title":"A guide to vaccinology: from basic principles to new developments","volume":"21","author":"Pollard","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.virusres.2026.199720_bib0130","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3390\/pharmaceutics15020451","article-title":"Aspects of nanotechnology for COVID-19 vaccine development and its delivery applications","volume":"15","author":"Prabhakar","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.virusres.2026.199720_bib0131","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/her\/cyaa043","article-title":"Intention to receive a vaccine against SARS-CoV-2 in Italy and its association with trust, worry and beliefs about the origin of the virus","volume":"35","author":"Prati","year":"2020","journal-title":"Health Educ. Res."},{"key":"10.1016\/j.virusres.2026.199720_bib0132","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/j.cgh.2014.06.018","article-title":"Polymeric nanoparticle technologies for oral drug delivery","volume":"12","author":"Pridgen","year":"2014","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.virusres.2026.199720_bib0133","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0057755","article-title":"Risk in vaccine research and development quantified","volume":"8","author":"Pronker","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.virusres.2026.199720_bib0134","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41573-021-00163-y","article-title":"Emerging concepts in the science of vaccine adjuvants","volume":"20","author":"Pulendran","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.virusres.2026.199720_bib0135","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41573-021-00163-y","article-title":"Emerging concepts in the science of vaccine adjuvants","volume":"20","author":"Pulendran","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.virusres.2026.199720_bib0137","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1080\/21645515.2020.1780846","article-title":"Social media and vaccine hesitancy: new updates for the era of COVID-19 and globalized infectious diseases","volume":"16","author":"Puri","year":"2020","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.virusres.2026.199720_bib0136","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s11705-018-1729-4","article-title":"Recent research and development of PLGA\/PLA microspheres\/nanoparticles: a review in scientific and industrial aspects","volume":"13","author":"Qi","year":"2019","journal-title":"Front. Chem. Sci. Eng."},{"key":"10.1016\/j.virusres.2026.199720_bib0138","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.3390\/vaccines12091002","article-title":"Novel administration routes, delivery vectors, and application of vaccines based on biotechnologies: a review","volume":"12","author":"Rai","year":"2024","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.virusres.2026.199720_bib0139","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/nri1670","article-title":"Dendritic-cell trafficking to lymph nodes through lymphatic vessels","volume":"5","author":"Randolph","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.virusres.2026.199720_bib0140","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/nri3085","article-title":"Vaccines for the twenty-first century society","volume":"11","author":"Rappuoli","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.virusres.2026.199720_bib0141","series-title":"Covid-19 Vaccine Hesitancy among Ethnic Minority Groups","author":"Razai","year":"2021"},{"key":"10.1016\/j.virusres.2026.199720_bib0142","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jconrel.2006.01.006","article-title":"In vivo targeting of dendritic cells in lymph nodes with poly (propylene sulfide) nanoparticles","volume":"112","author":"Reddy","year":"2006","journal-title":"J. Control Release"},{"key":"10.1016\/j.virusres.2026.199720_bib0143","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1038\/nm.3409","article-title":"Key roles of adjuvants in modern vaccines","volume":"19","author":"Reed","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.virusres.2026.199720_bib0144","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cell.2007.03.019","article-title":"Development in motion: helper T cells at work","volume":"129","author":"Reiner","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.virusres.2026.199720_bib0145","doi-asserted-by":"crossref","first-page":"6500","DOI":"10.1016\/j.vaccine.2020.08.043","article-title":"Acceptability of a COVID-19 vaccine among adults in the United States: how many people would get vaccinated?","volume":"38","author":"Reiter","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2026.199720_bib0146","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/08998280.2005.11928028","article-title":"Edward Jenner and the history of smallpox and vaccination","volume":"18","author":"Riedel","year":"2005","journal-title":"Bayl. Univ. Med. Cent. Proc."},{"key":"10.1016\/j.virusres.2026.199720_bib0147","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1128\/IAI.73.2.1141-1150.2005","article-title":"Antibody-mediated protection against cryptococcus neoformans pulmonary infection is dependent on B cells","volume":"73","author":"Rivera","year":"2005","journal-title":"Infect. Immun."},{"key":"10.1016\/j.virusres.2026.199720_bib0148","doi-asserted-by":"crossref","unstructured":"Robinson, H.L., Pertmer, T.M., 2000. DNA vaccines for viral infections: basic studies and applications.","DOI":"10.1016\/S0065-3527(00)55001-5"},{"key":"10.1016\/j.virusres.2026.199720_bib0149","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00428-018-2484-0","article-title":"Adoptive cellular therapies: the current landscape","volume":"474","author":"Rohaan","year":"2019","journal-title":"Virchows Arch."},{"key":"10.1016\/j.virusres.2026.199720_bib0150","doi-asserted-by":"crossref","DOI":"10.1098\/rsos.201199","article-title":"Susceptibility to misinformation about COVID-19 around the world","volume":"7","author":"Roozenbeek","year":"2020","journal-title":"R. Soc. Open Sci."},{"key":"10.1016\/j.virusres.2026.199720_bib0151","doi-asserted-by":"crossref","first-page":"5451","DOI":"10.4049\/jimmunol.1490019","article-title":"IL-2: the first effective immunotherapy for human cancer","volume":"192","author":"Rosenberg","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.virusres.2026.199720_bib0152","doi-asserted-by":"crossref","first-page":"3750","DOI":"10.1017\/S0033291720004067","article-title":"COVID-19 vaccine hesitancy is associated with beliefs on the origin of the novel coronavirus in the UK and Turkey","volume":"52","author":"Salali","year":"2022","journal-title":"Psychol. Med."},{"key":"10.1016\/j.virusres.2026.199720_bib0154","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3390\/vaccines9010042","article-title":"High rates of COVID-19 vaccine hesitancy and its association with conspiracy beliefs: a study in Jordan and Kuwait among other Arab countries","volume":"9","author":"Sallam","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.virusres.2026.199720_bib0153","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3390\/vaccines9020160","article-title":"COVID-19 vaccine hesitancy worldwide: a concise systematic review of vaccine acceptance rates","volume":"9","author":"Sallam","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.virusres.2026.199720_bib0155","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.immuni.2010.10.008","article-title":"From vaccines to memory and back","volume":"33","author":"Sallusto","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.virusres.2026.199720_bib0156","doi-asserted-by":"crossref","first-page":"873","DOI":"10.3390\/vaccines9080873","article-title":"Hesitant or not Hesitant? A systematic review on global COVID-19 vaccine acceptance in different populations","volume":"9","author":"Salomoni","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.virusres.2026.199720_bib0157","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2022.2026137","article-title":"Demographic factors associated with acceptance, hesitancy, and refusal of COVID-19 vaccine among residents of Sukkur during lockdown: a cross sectional study from Pakistan","volume":"18","author":"Samo","year":"2022","journal-title":"Hum. Vaccin. ImmunOther."},{"key":"10.1016\/j.virusres.2026.199720_bib0158","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S1473-3099(19)30231-2","article-title":"Measles resurgence in the USA: how international travel compounds vaccine resistance","volume":"19","author":"Sarkar","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.virusres.2026.199720_bib0159","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.arcmed.2020.05.012","article-title":"Structural proteins in severe acute respiratory syndrome coronavirus-2","volume":"51","author":"Satarker","year":"2020","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.virusres.2026.199720_bib0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0170550","article-title":"Barriers of influenza vaccination intention and behavior\u2013a systematic review of influenza vaccine hesitancy, 2005\u20132016","volume":"12","author":"Schmid","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.virusres.2026.199720_bib0161","doi-asserted-by":"crossref","first-page":"4157","DOI":"10.1016\/j.vaccine.2015.04.035","article-title":"Review of vaccine hesitancy: rationale, remit and methods","volume":"33","author":"Schuster","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2026.199720_bib0162","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3389\/fphar.2015.00286","article-title":"Advances and challenges of liposome assisted drug delivery","volume":"6","author":"Sercombe","year":"2015","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.virusres.2026.199720_bib0163","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0952-7915(03)00083-9","article-title":"Epitope-based vaccines: an update on epitope identification, vaccine design and delivery","volume":"15","author":"Sette","year":"2003","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.virusres.2026.199720_bib0164","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1002\/jmv.26478","article-title":"Questions concerning the proximal origin of SARS-CoV-2","volume":"93","author":"Seyran","year":"2021","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.virusres.2026.199720_bib0165","doi-asserted-by":"crossref","first-page":"5010","DOI":"10.1111\/febs.15651","article-title":"The structural basis of accelerated host cell entry by SARS-CoV-2\u2020","volume":"288","author":"Seyran","year":"2021","journal-title":"FEBS. J."},{"key":"10.1016\/j.virusres.2026.199720_bib0166","series-title":"Subunit Vaccine Delivery, Advances in Delivery Science and Technology","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/978-1-4939-1417-3_4","article-title":"Emulsions as vaccine adjuvants","author":"Shah","year":"2015"},{"key":"10.1016\/j.virusres.2026.199720_bib0167","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1039\/C7MD00158D","article-title":"Applications and perspectives of nanomaterials in novel vaccine development","volume":"9","author":"Shen","year":"2018","journal-title":"Medchemcomm."},{"key":"10.1016\/j.virusres.2026.199720_bib0168","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nbt.1769","article-title":"Gene therapy finds its niche","volume":"29","author":"Sheridan","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.virusres.2026.199720_bib0169","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1016\/j.vaccine.2019.04.055","article-title":"Vaccine adjuvants: understanding the structure and mechanism of adjuvanticity","volume":"37","author":"Shi","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2026.199720_bib0172","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.yexmp.2008.12.004","article-title":"Nanoparticle-based targeted drug delivery","volume":"86","author":"Singh","year":"2009","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.virusres.2026.199720_bib0171","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1586\/14760584.6.5.797","article-title":"Nanoparticles and microparticles as vaccine-delivery systems","volume":"6","author":"Singh","year":"2007","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.virusres.2026.199720_bib0170","series-title":"Vaccine Adjuvants and Delivery Systems","author":"Singh","year":"2007"},{"key":"10.1016\/j.virusres.2026.199720_bib0173","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/jlb.64.6.713","article-title":"ISCOMs: an adjuvant with multiple functions","volume":"64","author":"Sj\u00f6lander","year":"1998","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.virusres.2026.199720_bib0174","first-page":"1486","article-title":"Synthesis and properties of mRNAs containing the novel \u201canti-reverse\u201d cap analogs 7-methyl (3\u2032-O-methyl) GpppG and 7-methyl (3\u2032-deoxy) GpppG","volume":"7","author":"STEPINSKI","year":"2001","journal-title":"Rna"},{"key":"10.1016\/j.virusres.2026.199720_bib0175","first-page":"333","article-title":"Immunity in response to particulate antigen-delivery systems. Advanced drug delivery reviews","volume":"57","author":"Storni","year":"2005","journal-title":"Trends Part. Antigen DNA Deliv. Syst. Vaccines"},{"key":"10.1016\/j.virusres.2026.199720_bib0176","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1080\/10854681.2020.1780664","article-title":"Balancing speed and safety: the authorisation of Covid-19 vaccines and medicines","volume":"25","author":"Stratford","year":"2020","journal-title":"Judic. Rev."},{"key":"10.1016\/j.virusres.2026.199720_bib0177","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1039\/b9nj00644c","article-title":"Towards mRNA with superior translational activity: synthesis and properties of ARCA tetraphosphates with single phosphorothioate modifications","volume":"34","author":"Strenkowska","year":"2010","journal-title":"New J. Chem."},{"key":"10.1016\/j.virusres.2026.199720_bib0178","doi-asserted-by":"crossref","first-page":"658","DOI":"10.3390\/vaccines11030658","article-title":"Recent advances in the lipid nanoparticle-mediated delivery of mRNA vaccines","volume":"11","author":"Swetha","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.virusres.2026.199720_bib0179","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1039\/C5TB01825K","article-title":"Materials design at the interface of nanoparticles and innate immunity","volume":"4","author":"Szeto","year":"2016","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.virusres.2026.199720_bib0180","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1435426","article-title":"Exosomes: the next frontier in vaccine development and delivery","volume":"15","author":"Tan","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.virusres.2026.199720_bib0182","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2020.575950","article-title":"A proactive approach for managing COVID-19: the importance of understanding the motivational roots of vaccination hesitancy for SARS-CoV2","volume":"11","author":"Taylor","year":"2020","journal-title":"Front. Psychol."},{"key":"10.1016\/j.virusres.2026.199720_bib0181","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/s41577-021-00542-x","article-title":"Neutralizing monoclonal antibodies for treatment of COVID-19","volume":"21","author":"Taylor","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.virusres.2026.199720_bib0183","doi-asserted-by":"crossref","first-page":"113","DOI":"10.46234\/ccdcw2020.032","article-title":"The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19)\u2014China, 2020","volume":"2","author":"Team","year":"2020","journal-title":"China CDC Wkly."},{"key":"10.1016\/j.virusres.2026.199720_bib0184","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/s41586-021-03792-w","article-title":"After the pandemic: perspectives on the future trajectory of COVID-19","volume":"596","author":"Telenti","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.virusres.2026.199720_bib0185","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s11671-023-03943-0","article-title":"Exploration of inorganic nanoparticles for revolutionary drug delivery applications: a critical review","volume":"18","author":"Unnikrishnan","year":"2023","journal-title":"Discov. Nano"},{"key":"10.1016\/j.virusres.2026.199720_bib0186","first-page":"49","article-title":"Highly efficient gene delivery by mRNA electroporation in human hematopoietic cells: superiority to lipofection and passive pulsing of mRNA and to electroporation of plasmid cDNA for tumor antigen loading of dendritic cells. Blood","volume":"98","author":"Van Tendeloo","year":"2001","journal-title":"J. Am. Soc. Hematol."},{"key":"10.1016\/j.virusres.2026.199720_bib0187","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/gt.2016.79","article-title":"Graphene materials as 2D non-viral gene transfer vector platforms","volume":"24","author":"Vincent","year":"2017","journal-title":"Gene Ther."},{"issue":"1317","key":"10.1016\/j.virusres.2026.199720_bib0188","first-page":"1319","article-title":"[The mechanism of diphtheria immunity and tetanus immunity in animals. 1890]","volume":"28","author":"von Behring","year":"1991","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.virusres.2026.199720_bib0189","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/B978-0-12-821749-8.00010-0","article-title":"Long-lasting drug delivery systems based on microneedles","author":"Vora","year":"2022","journal-title":"Long-Acting Drug Delivery Systems"},{"key":"10.1016\/j.virusres.2026.199720_bib0190","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0140-6736(20)30300-7","article-title":"What to do next to control the 2019-nCoV epidemic?","volume":"395","author":"Wang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.virusres.2026.199720_bib0192","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jconrel.2019.04.025","article-title":"Liposomes used as a vaccine adjuvant-delivery system: from basics to clinical immunization","volume":"303","author":"Wang","year":"2019","journal-title":"J. Control Release"},{"key":"10.1016\/j.virusres.2026.199720_bib0191","doi-asserted-by":"crossref","first-page":"482","DOI":"10.3390\/vaccines8030482","article-title":"Acceptance of COVID-19 vaccination during the COVID-19 pandemic in China","volume":"8","author":"Wang","year":"2020","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.virusres.2026.199720_bib0193","series-title":"Welcome to Vaccines Prequalification | WHO - Prequalification of Medical Products (IVDs, Medicines","year":"2019"},{"key":"10.1016\/j.virusres.2026.199720_bib0194","unstructured":"WHO, 2019b Ten health issues WHO will tackle this year [WWW Document]. URL https:\/\/www.who.int\/news-room\/spotlight\/ten-threats-to-global-health-in-2019 (accessed 2.18.25)."},{"key":"10.1016\/j.virusres.2026.199720_bib0195","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1111\/bjhp.12468","article-title":"Towards intervention development to increase the uptake of COVID-19 vaccination among those at high risk: outlining evidence-based and theoretically informed future intervention content","volume":"25","author":"Williams","year":"2020","journal-title":"Br. J. Health Psychol."},{"key":"10.1016\/j.virusres.2026.199720_bib0196","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.ejpb.2008.09.016","article-title":"Current prospects for mRNA gene delivery","volume":"71","author":"Yamamoto","year":"2009","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.virusres.2026.199720_bib0197","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.socscimed.2014.04.018","article-title":"Attitudes to vaccination: a critical review","volume":"112","author":"Yaqub","year":"2014","journal-title":"Soc. Sci. Med."},{"key":"10.1016\/j.virusres.2026.199720_bib0198","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2023.2256040","article-title":"A review of technological developments in lipid nanoparticle application for mRNA vaccination","volume":"19","author":"Yeh","year":"2023","journal-title":"Hum. Vaccin. ImmunOther."},{"key":"10.1016\/j.virusres.2026.199720_bib0199","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-024-01868-3","article-title":"Targeting cytokine and chemokine signaling pathways for cancer therapy","volume":"9","author":"Yi","year":"2024","journal-title":"Sig. Transduct. Target Ther."},{"key":"10.1016\/j.virusres.2026.199720_bib0200","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nrg3763","article-title":"Non-viral vectors for gene-based therapy","volume":"15","author":"Yin","year":"2014","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.virusres.2026.199720_bib0201","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1517\/14712598.2015.1057563","article-title":"Modified mRNA as an alternative to plasmid DNA (pDNA) for transcript replacement and vaccination therapy","volume":"15","author":"Youn","year":"2015","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.virusres.2026.199720_bib0202","doi-asserted-by":"crossref","first-page":"490","DOI":"10.3390\/vaccines11020490","article-title":"Recent developments in oral delivery of vaccines using nanocarriers","volume":"11","author":"Zafar","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.virusres.2026.199720_bib0203","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/sj.clpt.6100400","article-title":"Nanoparticles in medicine: therapeutic applications and developments","volume":"83","author":"Zhang","year":"2008","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.virusres.2026.199720_bib0205","doi-asserted-by":"crossref","first-page":"e1559","DOI":"10.1002\/wnan.1559","article-title":"Nanovaccines for cancer immunotherapy","volume":"11","author":"Zhang","year":"2019","journal-title":"WIREs Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.virusres.2026.199720_bib0204","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s13045-023-01492-8","article-title":"Challenges and new technologies in adoptive cell therapy","volume":"16","author":"Zhang","year":"2023","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.virusres.2026.199720_bib0206","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.vaccine.2013.11.069","article-title":"Nanoparticle vaccines","volume":"32","author":"Zhao","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2026.199720_bib0207","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ijid.2020.01.050","article-title":"Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: a data-driven analysis in the early phase of the outbreak","volume":"92","author":"Zhao","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.virusres.2026.199720_bib0208","doi-asserted-by":"crossref","DOI":"10.1016\/j.tmaid.2020.101568","article-title":"The association between domestic train transportation and novel coronavirus (2019-nCoV) outbreak in China from 2019 to 2020: a data-driven correlational report","volume":"33","author":"Zhao","year":"2020","journal-title":"Travel. Med. Infect. Dis."},{"key":"10.1016\/j.virusres.2026.199720_bib0209","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-023-01557-7","article-title":"Vaccine adjuvants: mechanisms and platforms","volume":"8","author":"Zhao","year":"2023","journal-title":"Sig. Transduct. Target Ther."},{"key":"10.1016\/j.virusres.2026.199720_bib0210","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1186\/s12951-024-02758-0","article-title":"Tailoring biomaterials for vaccine delivery","volume":"22","author":"Zhuo","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.virusres.2026.199720_bib0211","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.bbrc.2007.04.059","article-title":"Effective delivery with enhanced translational activity synergistically accelerates mRNA-based transfection","volume":"358","author":"Zohra","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.virusres.2026.199720_bib0212","series-title":"The Importance of Injecting Vaccines into Muscle: Different Patients Need Different Needle Sizes","author":"Zuckerman","year":"2000"}],"container-title":["Virus Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170226000389?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170226000389?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T16:45:29Z","timestamp":1777999529000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168170226000389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":212,"alternative-id":["S0168170226000389"],"URL":"https:\/\/doi.org\/10.1016\/j.virusres.2026.199720","relation":{},"ISSN":["0168-1702"],"issn-type":[{"value":"0168-1702","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A systematic review on vaccine developmental approaches: Evaluating efficacy, and addressing challenges of infectious diseases in the post-COVID-19 era","name":"articletitle","label":"Article Title"},{"value":"Virus Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virusres.2026.199720","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"199720"}}